Oragenics Inc (OGEN)
NYSE MKT:OGEN
Holding OGEN?
Track your performance easily

Oragenics (OGEN) Income Statement

967 Followers

Oragenics Income Statement

Last quarter (Q2 2024), Oragenics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q2, Oragenics's net income was $-2.31M. See Oragenics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 20.66K$ 131.52K$ 86.99K$ 0.00$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 20.63K$ 131.52K$ 86.99K---
Operating Expense
$ 5.07M$ 14.55M$ 15.86M$ 26.64M$ 15.88M$ 10.00M
Operating Income
$ -9.97M$ -14.42M$ -15.77M$ -26.64M$ -15.88M$ -10.00M
Net Non Operating Interest Income Expense
$ 113.11K$ 115.66K$ 58.73K$ 78.61K$ 312.71K$ 80.74K
Other Income Expense
$ -45.74K$ -11.58K$ -670.00$ 134.55K$ 456.00$ 446.00
Pretax Income
$ -9.82M$ -14.29M$ -15.71M$ -26.43M$ -15.57M$ -9.91M
Tax Provision
-$ -3.71M$ -870.94K$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -9.82M$ -14.29M$ -15.71M$ -26.43M$ -15.57M$ -11.33M
Basic EPS
$ -3.57$ -7.11$ -8.09$ -0.47$ -0.37$ -0.87
Diluted EPS
$ -3.57$ -7.11$ -8.09$ -0.47$ -0.37$ -0.87
Basic Average Shares
$ 12.41M$ 2.01M$ 1.94M$ 56.53M$ 42.28M$ 13.04M
Diluted Average Shares
$ 12.41M$ 2.01M$ 1.94M$ 56.53M$ 42.28M$ 13.04M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 5.07M$ 14.55M$ 15.86M$ 26.64M$ 15.88M$ 10.00M
Net Income From Continuing And Discontinued Operation
$ -9.82M$ -14.29M$ -15.71M$ -26.43M$ -15.57M$ -9.91M
Normalized Income
$ -6.28M--$ -26.56M$ -15.57M$ -9.91M
Interest Expense
---$ 10.69K$ 7.30K$ 5.79K
EBIT
$ -4.88M$ -14.27M$ -15.70M$ -26.42M$ -15.56M$ -9.91M
EBITDA
$ -4.86M$ -14.23M$ -15.65M$ -26.37M$ -15.50M$ -9.88M
Currency in USD

Oragenics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis